Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy. (2022)
Attributed to:
Definition and induction of broadly protective responses against HIV-1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000003121
PubMed Identifier: 34750296
Publication URI: http://europepmc.org/abstract/MED/34750296
Type: Journal Article/Review
Volume: 36
Parent Publication: AIDS (London, England)
Issue: 3
ISSN: 0269-9370